PUBLISHER: Inkwood Research | PRODUCT CODE: 1071604
PUBLISHER: Inkwood Research | PRODUCT CODE: 1071604
The Asia-Pacific proteomics market is set to project a CAGR of 15.95% during the forecast period, 2022-2030. The region encompasses increased demands and need for novel drug discovery, and more reliable & faster disease diagnosis, given the surging pressure on the healthcare sector.
South Korea, India, Australia & New Zealand, Vietnam, Thailand, Japan, Indonesia, China, and Rest of Asia-Pacific are evaluated for the Asia-Pacific proteomics market growth assessment. Japan houses a number of well-established industry players that offer lab support, reagents, kits, instruments, products, and complete proteomics services and solutions. Some of the Japanese players that operate internationally and domestically include HORIBA Group, Japan Electron Optics Laboratory Co Ltd, Shimadzu Corporation, etc. The strategic developments by these market players enable innovations and technological advancements and attract partnerships, collaborations, and foreign investments, which contribute to the country's growth prospects.
In Indonesia, the presence of relevant research organizations and institutes contributes to market growth. For instance, the Molecular Biology and Proteomics Core Facilities (MBPCF) offer molecular biology and proteomics services and equipment important central to biomedical science. Also, it provides research facilities and services of sample analysis and consultation.
In the case of Australia, the Australian Proteomics Society (APS) facilitates and promotes proteomics research and related topics in Australia and New Zealand. Its membership is drawn from government, industry, and academic laboratories. In Thailand, the efforts by institutes in terms of enzymes and proteins with evident biochemical properties, which could further aid in the medical & pharmaceutical applications, food & biotechnology industrial applications, and industrial & agricultural applications, boost market demands.
Some of the eminent firms in the market include: MS Bioworks, Promega Corporation, PerkinElmer Inc, Sengenics, etc.